Today, the Eliava Institute of Bacteriophages, Microbiology and Virology (IBMV) continues its rich tradition of work in applied microbiology and bacteriophage research. The main goal of the ongoing research is the development of ecologically safe biopreparations and appropriate methodologies for their future application for human and animal health, agriculture and environmental protection.
The Eliava Institute implements projects in the following fields:
· Bacteriophage Research
· Phage Diagnostics, Therapy and Prophylaxis
· Clinical Microbiology
· Environmental Microbiology
· Food Microbiology
· Infectious Immunology
· Microbial and Phage Genetics
· Plant protection
Eliava scientists are conducting world-class research in such areas as:
·Investigation of the etiological structure of human and animal bacterial pathogens, including antibiotic-resistant infections and the development of specific phage preparations against these pathogens;
·Isolation and selection of new, specific bacteriophages with therapeutic potential and their detailed characterization;
·Elaboration of biological preparations (bacteriophages and enzymes) against highly contagious human and animal pathogens;
· Ecological monitoring of bacterial pollution in water environments.
·Elaboration of the ecologically safe phage-based technologies for detection and eradication of the bacterial pathogens in different environments.
·Working out a novel strategy for phage-based bio-control of plant bacterial diseases.
Since the 1950s, Eliava scientists have developed several dozen biopreparations, including phage cocktails (mixtures), vaccines, diagnostic and therapeutic immune sera, bacterial preparations (probiotics), enzymes, and more. The following preparations should be especially emphasized:
Since the fifties of the last century, Eliava Institute’s scientists have elaborated several dozens of bio-preparations, including phage cocktails (mixtures), vaccines, diagnostic and therapeutic immune sera, bacterial preparations (probiotics), enzymes, etc. Following preparations should be especially emphasized:
· Series of monophages
· Anthrax vaccine “STI-1”
· Heterogenic Immunoglobulin for treatment of Anthrax
· Enzyme “Bilidase” (bacterial hyaluronidase)
· Anti-Staphylococcal heterogenic γ-globulin and antitoxin
Since 1994, Eliava scientists have received roughly 60 international grants and scholarships, supported by a wide range of international funding agencies including the Georgian National Science Foundation, the Civilian Research and Development Foundation, the International Science and Technology Center, the Science and Technology Center of Ukraine, the Defense Threat Reduction agency, the International European science foundation INTAS, NATO, and others.